Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,683,824
-
Share change
-
+1,524,014
-
Total reported value
-
$14,095,638
-
Put/Call ratio
-
55%
-
Price per share
-
$3.01
-
Number of holders
-
42
-
Value change
-
+$8,417,966
-
Number of buys
-
40
-
Number of sells
-
2
Institutional Holders of Fortress Biotech, Inc. - COM NEW (FBIO) as of Q4 2023
As of 31 Dec 2023,
Fortress Biotech, Inc. - COM NEW (FBIO) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,683,824 shares.
The largest 10 holders included
CVI Holdings, LLC, Rosalind Advisors, Inc., ARMISTICE CAPITAL, LLC, Altium Capital Management LP, Nantahala Capital Management, LLC, VANGUARD GROUP INC, Hudson Bay Capital Management LP, SHIKIAR ASSET MANAGEMENT INC, PVG ASSET MANAGEMENT CORP, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.